Lutetium-177 PSMA (Prostate specific membrane antigen) treatment is a form of radionuclide therapy that aims to destroy prostate cancer cells that have spread into parts of the body, including lymph nodes and bones.

The destruction of the prostate cancer cells may prolong life expectancy and also potentially alleviate any symptoms such as bone pain frequently associated with deposits of cancer in the skeleton.

For more information click here